Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart BDR | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$4.17T | 40.7x | 92.98 | R$32.75 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kroger Co | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$239.58B | 18.3x | 0.69 | R$359.89 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sysco | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$196.91B | 18.2x | -3.4 | R$205.54 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano DRC | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$190.61B | 25.1x | 0.52 | R$588.23 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RAIADROGASIL ON | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$24.53B | 20.1x | 1.51 | R$14.32 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.7% Upside | Upgrade to Pro+ | |
Grupo Mateus | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$17.85B | 12.6x | 0.93 | R$7.95 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$14.89B | 18.8x | 0.98 | R$11.04 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.1% Upside | Upgrade to Pro+ | |
Pague Menos | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$2.12B | 48.7x | 1.33 | R$3.42 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14% Upside | Upgrade to Pro+ | |
Brasileira De Dist | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.50B | -1.1x | -0.02 | R$3.06 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.3% Downside | Upgrade to Pro+ | |
Dimed | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.34B | 13.5x | -1.06 | R$9.02 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33% Upside | Upgrade to Pro+ | |
D1000 On | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$252.51M | 10.8x | 2.47 | R$4.99 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.3% Upside | Upgrade to Pro+ |